Clinical Trials Directory

Trials / Completed

CompletedNCT05958966

Effects of e-Cigarettes on Perceptions and Behavior - Substudy 2

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
73 (actual)
Sponsor
University of Southern California · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

This project will assess the ways in which e-cigarette product diversity impacts the user experience to inform potential regulations by identifying product characteristics that may: (1) put young adults at risk for tobacco product use; and (2) facilitate adult smokers switching to e-cigarettes. There are three primary objectives to the study: (1) Determine which dimensions of e-cigarette product diversity differentially affect product appeal in the overall population of tobacco product users as well as affect product appeal across young adult e-cigarette users and middle-age/older adult smokers; (2) Determine which dimensions of e-cigarette product diversity differentially affect product appeal in the overall population of tobacco product users as well as affect abuse liability in young adult e-cigarette users and the ability to resist smoking in adult smokers; (3) Determine the affect of product characteristics on e-cigarette nicotine delivery profile. For this substudy, adult smokers (N=200) will attend two laboratory session in which they will self-administer e-cigarette products varied according to within-subject e-cigarette factors (e.g., flavor, nicotine formulation) and smoke their own cigarettes.

Conditions

Interventions

TypeNameDescription
OTHERE-cigarette e-liquid self-administrationParticipant will self-administer an experimenter-provided e-cigarette.

Timeline

Start date
2022-04-01
Primary completion
2023-05-01
Completion
2023-05-01
First posted
2023-07-25
Last updated
2023-07-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05958966. Inclusion in this directory is not an endorsement.

Effects of e-Cigarettes on Perceptions and Behavior - Substudy 2 (NCT05958966) · Clinical Trials Directory